<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>8532940</identifier>
<setSpec>0300-8932</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Errazquin, F</dc:author>
<dc:author>Pedrote, A</dc:author>
<dc:description xml:lang="en">Sudden cardiac death is a major medical problem. The techniques to identify high risk patients have a limited value. Only betablockers, and perhaps amiodarone, are useful for primary prevention of sudden cardiac death. Prospective studies being carried out today with implantable cardioverter-defibrillator, will show us if these are the best way of treatment (secondary prevention) of sudden cardiac death.</dc:description>
<dc:type>English Abstract</dc:type>
<dc:language>es</dc:language>
<dc:date>1995 Nov </dc:date>
<dc:title xml:lang="es">Estado actual de la prevención y tratamiento de la muerte súbita.</dc:title>
<dc:title xml:lang="en">[The current status of the prevention and treatment of sudden death].</dc:title>
<dc:publisher>Revista espanola de cardiologia</dc:publisher>
</metadata>
</record>
</pubmed-document>
